glp-1/gip peptide Role of a Dual Glucose-Dependent Insulinotropic (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment GLP-1 and GIP receptor signaling

In 2024 Wegovy was the first drug approved by the FDA to treat cardiovascular disease in people with obesity

The abdomen has higher baseline blood flow than the thigh, which is one reason it is associated with slightly faster absorption

Given all this, its likely GLP-1s will become even more popular now that theyre no longer confined to injectable versions

TorHorman Law is awesome I cant say enough how grateful I was to have TorHoerman Law help with my case

Most said that supplements cant hurt as an adjunct to other treatments but theres not much evidence that theyll move the needle

However, oral bioavailability is only about 1%, meaning you need a much higher absolute dose to achieve comparable blood levels to the injectable form